Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
FLGC 
Flora Growth Corp (FLGC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/19/2025: FLGC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
2 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $30
1 Year Target Price $30
| 1 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -93.47% | Avg. Invested days 21 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/19/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 5.81M USD | Price to earnings Ratio - | 1Y Target Price 30 |
Price to earnings Ratio - | 1Y Target Price 30 | ||
Volume (30-day avg) 2 | Beta 1.87 | 52 Weeks Range 6.80 - 47.00 | Updated Date 12/13/2025 |
52 Weeks Range 6.80 - 47.00 | Updated Date 12/13/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -41.09 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -27.7% | Operating Margin (TTM) -33.5% |
Management Effectiveness
Return on Assets (TTM) -17.55% | Return on Equity (TTM) -45.26% |
Valuation
Trailing PE - | Forward PE 7.89 | Enterprise Value -4395819 | Price to Sales(TTM) 0.09 |
Enterprise Value -4395819 | Price to Sales(TTM) 0.09 | ||
Enterprise Value to Revenue 0.37 | Enterprise Value to EBITDA -1 | Shares Outstanding 741261 | Shares Floating 613514 |
Shares Outstanding 741261 | Shares Floating 613514 | ||
Percent Insiders 16.61 | Percent Institutions 2.05 |
Upturn AI SWOT
Flora Growth Corp
Company Overview
History and Background
Flora Growth Corp. was founded in 2019 with the ambition to be a leading global producer of high-quality, sustainable, and affordable cannabis and hemp-derived products. A significant milestone was the construction and operationalization of its state-of-the-art indoor cultivation facility in Portugal. The company has evolved to focus on leveraging its proprietary cultivation and extraction technologies to serve a growing international market.
Core Business Areas
- Cultivation and Extraction: Flora Growth Corp. operates a large-scale, fully automated indoor cultivation facility in Portugal, designed for optimal cannabis and hemp growth. This segment focuses on producing high-quality biomass and extracts through proprietary technologies. They aim to achieve significant cost efficiencies and superior product quality.
- Product Development and Manufacturing: The company develops and manufactures a range of consumer-facing products derived from its cultivated cannabis and hemp. This includes oils, tinctures, topicals, and potentially beverages and edibles, targeting various wellness and lifestyle segments. They also have capabilities for white-labeling and private-labeling services.
- Global Distribution and Sales: Flora Growth Corp. is building a global distribution network to bring its products to international markets where regulations permit. This involves establishing partnerships and sales channels across Europe and potentially other regions, focusing on both direct-to-consumer and business-to-business sales.
Leadership and Structure
Flora Growth Corp. is led by a management team with experience in agriculture, technology, and consumer goods. The organizational structure is designed to support its integrated business model, from cultivation to product development and global sales. Specific leadership roles and their biographies are typically found in company filings and on their corporate website.
Top Products and Market Share
Key Offerings
- Product Name 1: Hemp-Derived CBD Oils and Tinctures: These are flagship products focusing on wellness and therapeutic benefits. Competitors include Charlotte's Web (CWEB), CBDfx, and numerous smaller brands. Market share data for specific Flora Growth products is not readily available publicly, but the broader CBD market is highly fragmented.
- Product Name 2: Cannabis-Derived Extracts: For markets where recreational or medical cannabis is legalized, Flora Growth produces high-quality cannabis extracts for various applications. Competitors in this space are highly localized and depend on the specific regulatory environment. Market share is difficult to quantify due to regulatory fragmentation.
- Product Name 3: White-Label and Private-Label Services: Flora Growth offers its cultivation and extraction expertise to other brands. This segment competes with contract manufacturers and cultivators globally. Revenue and market share for this specific service are not publicly detailed.
Market Dynamics
Industry Overview
Flora Growth Corp. operates within the global cannabis and hemp industries. The cannabis industry is characterized by rapid growth, significant regulatory evolution across different jurisdictions, and increasing consumer acceptance. The hemp-derived CBD market is also expanding but faces challenges related to regulatory clarity and market saturation.
Positioning
Flora Growth Corp. positions itself as a technologically advanced, low-cost, and high-quality producer. Its key competitive advantages lie in its proprietary cultivation technology (e.g., automated indoor farming) leading to cost efficiencies and consistent product quality, and its strategically located, large-scale facility in Portugal, offering access to European markets.
Total Addressable Market (TAM)
The global cannabis market is projected to reach hundreds of billions of dollars in the coming years, with the CBD market also representing a significant portion of this. Flora Growth Corp. is positioned to capture a portion of this TAM by focusing on high-quality, cost-effective production and by strategically entering markets with favorable regulatory frameworks. Their success will depend on their ability to scale production and establish strong distribution channels.
Upturn SWOT Analysis
Strengths
- Proprietary cultivation and extraction technologies leading to cost efficiency and quality control.
- State-of-the-art, large-scale indoor cultivation facility in Portugal.
- Focus on sustainability and efficient resource utilization.
- Experienced management team with diverse industry backgrounds.
- Strategic location for access to European markets.
Weaknesses
- Relatively new company with a developing track record and brand recognition.
- Dependence on evolving regulatory landscapes in various international markets.
- Need for significant capital investment to scale operations and expand market reach.
- Potential challenges in global supply chain management.
Opportunities
- Growing global demand for cannabis and hemp-derived products.
- Expansion into new international markets as regulations liberalize.
- Development of new, innovative product lines.
- Strategic partnerships and collaborations.
- Increasing consumer awareness and acceptance of cannabis products for wellness.
Threats
- Regulatory uncertainty and changes in cannabis and hemp laws globally.
- Increased competition from established and emerging players.
- Price volatility and commoditization of products.
- Potential for adverse health studies or public perception shifts.
- Economic downturns impacting consumer spending on non-essential goods.
Competitors and Market Share
Key Competitors
- Canopy Growth Corporation (CGC)
- Tilray Brands, Inc. (TLRY)
- Aurora Cannabis Inc. (ACB)
- Cronos Group Inc. (CRON)
Competitive Landscape
Flora Growth Corp. operates in a highly competitive and regulated global cannabis market. While it benefits from its advanced cultivation technology and cost efficiencies, it faces competition from larger, more established players with greater brand recognition and market penetration. Its advantages lie in its focus on sustainability and potential for lower production costs. Disadvantages include its smaller scale compared to some giants and its dependence on emerging markets.
Major Acquisitions
Uprearing
- Year: 2022
- Acquisition Price (USD millions): 1.7
- Strategic Rationale: To expand its beverage offerings and gain a foothold in the ready-to-drink (RTD) market, enhancing its product portfolio with established brands.
Kona Gold Beverage
- Year: 2021
- Acquisition Price (USD millions):
- Strategic Rationale: To integrate established brands and distribution in the functional beverage and CBD beverage space, providing immediate revenue streams and market access.
Growth Trajectory and Initiatives
Historical Growth: Flora Growth Corp.'s historical growth has been characterized by the development and expansion of its cultivation infrastructure and initial product launches. Revenue generation has been increasing as operations scale.
Future Projections: Future projections for Flora Growth Corp. would typically be based on analyst estimates, industry growth trends, and the company's expansion plans into new markets and product categories. These projections often anticipate significant revenue growth as production capacity is fully utilized and global distribution expands.
Recent Initiatives: Recent initiatives may include expanding cultivation capacity, developing new product formulations, securing international distribution agreements, and potentially pursuing strategic acquisitions to broaden its portfolio or market reach.
Summary
Flora Growth Corp. is a developing player in the global cannabis and hemp industry, leveraging advanced cultivation technology for cost-efficient, high-quality production. Its strengths lie in its innovative operational approach and strategic Portuguese facility. However, it faces significant challenges due to intense competition, regulatory uncertainties, and the need for substantial capital to scale and achieve profitability. The company's success hinges on its ability to effectively navigate these challenges and capitalize on the growing international demand for cannabis products.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Flora Growth Corp. SEC Filings (10-K, 10-Q)
- Company Investor Relations Materials
- Reputable Financial News Outlets
- Industry Market Research Reports
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It does not constitute financial advice. Investors should conduct their own due diligence before making any investment decisions. Market share data is an estimation and may not reflect precise current figures due to the dynamic nature of the industry and reporting variations.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Flora Growth Corp
Exchange NASDAQ | Headquaters Fort Lauderdale, FL, United States | ||
IPO Launch date 2021-05-11 | CEO & Director Mr. Daniel Reis-Faria | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 64 | Website https://www.floragrowth.com |
Full time employees 64 | Website https://www.floragrowth.com | ||
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. The company operates in two segments: Commercial and Wholesale, House of Brands. It cultivates, processes, and supplies medicinal-grade cannabis flower, as well as cannabis derived medical and wellness products. The company also offers food and beverage, nutraceutical, cannabis accessories and technology, personal care, and wellness products; and cannabis consumption accessories, as well as personal storage and travel accessories for the vape and dry herbs. In addition, it manufactures and distributes pharmaceutical goods and medical cannabis products to treat a range of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. Further, the company sells its products under the JustCBD, Vessel, and Phatebo brand names. Flora Growth Corp. was incorporated in 2019 and is headquartered in Fort Lauderdale, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.